Comparative effects of SGLT2 inhibitors and incretin-based therapies on dementia risk in type 2 diabetes: a systematic review and meta-analysis. [PDF]
Front Endocrinol (Lausanne)Song K +6 more
europepmc +1 more source
Positron emission tomography to assess drug occupancy at peripheral and central incretin receptors. [PDF]
EBioMedicineKhalil A +5 more
europepmc +1 more source
New-Onset Atrial Fibrillation Potentially Associated With Tirzepatide: A Case Report. [PDF]
CureusPurvez A, Mirza M, Bashir M.
europepmc +1 more source
Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review. [PDF]
NutrientsBarana L +7 more
europepmc +1 more source
Gastrointestinal Adverse Effects of Anti-Obesity Medications in Non-Diabetic Adults: A Systematic Review. [PDF]
Medicina (Kaunas)Takrori E, Peshin S, Singal S.
europepmc +1 more source
Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes. [PDF]
Diabetes CareFang YE +5 more
europepmc +1 more source
Letter response to Van Bruggen: Obesity, sleep apnea and incretin therapy. [PDF]
Sleep MedMalhotra A, Bednarik J.
europepmc +1 more source
GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity. [PDF]
J Clin InvestCooper ME, van Raalte DH.
europepmc +1 more source
Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice. [PDF]
J Clin InvestMcMorrow HE +8 more
europepmc +1 more source